Relapsed or Refractory
2 clinical trials · Condition
◉ Watch Relapsed or Refractory
| Record | Firm | Date |
|---|---|---|
| Chiauranib Plus Weekly Paclitaxel in Patients with Platinum-refractory or Platinum-resistant Recurrent Ovarian Cancer (NCT04921527) | Chipscreen Biosciences, Ltd. | 2021-12-20 |
| Combination Therapy With Carfilzomib, Romidepsin, Lenalidomide in Patients With Relapsed or Refractory B- and T-cell Lymphomas (NCT02341014) | Memorial Sloan Kettering Cancer Center | 2015-01-02 |
Track Relapsed or Refractory automatically
Every clearance here is in the API, with alerts when new ones post.